The Trump administration is ending a Medicare drug subsidy program. Here's how it could affect costs

The Trump administration is ending a Medicare Part D subsidy program, which could lead to higher monthly costs for 25 million beneficiaries starting in 2027. The program, initially implemented by the Biden administration in 2024, offset prescription drug premiums. Federal officials claim the impact will be minimal, but Democrats criticize the move as increasing healthcare costs for seniors.